MPP Strikes Landmark Licensing Deal With Novartis On Nilotinib

Agreement On Tasigna Generics Represents First Such Deal For A Cancer Medicine

 
• By Dave Wallace
  
Novartis logo building
Novartis has signed a voluntary licensing deal with the MPP for nilotinib • Source: Shutterstock

More from Legal & IP

More from Pink Sheet